MARY KELLER: Open Payments
NPI 1992727259 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$842 in 38 payments from 16 companies in 2025. Trend: 2023 $1,498 · 2024 $1,706 · 2025 $842
Food & beverage: $820Education: $22
| Company | Payments | Amount |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 6 | $178 |
| Novartis Pharmaceuticals Corporation | 6 | $131 |
| Calliditas Therapeutics US Inc. | 4 | $88 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Amgen Inc. | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Ardelyx, Inc. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Apellis Pharmaceuticals, Inc. | 1 | $28 |
Products named: PURIFIED CORTROPHIN GEL, Fabhalta, TARPEYO, JYNARQUE, BENLYSTA, IBSRELA, KRYSTEXXA, JARDIANCE.
Industry payments across WI — which companies pay providers there.
